Albarrak May, Alzomor Omar, Almaghrabi Rana, Alsubaie Sarah, Alghamdi Faisal, Bajouda Asrar, Nojoom Maha, Faqeehi Hassan, Rubeea Subhy Abo, Alnafeesah Razan, Dolgum Saeed, ALghoshimi Mohammed, AlHajjar Sami, AlShahrani Dayel
Pediatric Infectious Diseases, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Pediatric Infectious Diseases, King Saud Medical City, Riyadh, Saudi Arabia.
Int J Pediatr Adolesc Med. 2021 Jun;8(2):57-67. doi: 10.1016/j.ijpam.2021.03.001. Epub 2021 Mar 11.
Urinary tract infection (UTI) is the most common bacterial disease in childhood worldwide and may have significant adverse consequences, particularly for young children. In this guideline, we provide the most up-to-date information for the diagnosis and management of community-acquired UTI in infants and children aged over 90 days up to 14 years. The current recommendations given by the American Academy of Pediatrics Practice guidelines, Canadian Pediatric Society guideline, and other international guidelines are considered as well as regional variations in susceptibility patterns and resources. This guideline covers the diagnosis, therapeutic options, and prophylaxis for the management of community-acquired UTI in children guided by our local antimicrobial resistance pattern of the most frequent urinary pathogens. Neonates, infants younger than three months, immunocompromised patients, children recurrent UTIs, or renal abnormalities should be managed individually because these patients may require more extensive investigation and more aggressive therapy and follow up, so it is considered out of the scope of these guidelines. Establishment of children-specific guidelines for the diagnosis and management of community-acquired UTI can reduce morbidity and mortality. We present a clinical statement from the Saudi Pediatric Infectious Diseases Society (SPIDS), which concerns the diagnosis and management of community-acquired UTI in children.
尿路感染（UTI）是全球儿童期最常见的细菌性疾病，可能会产生严重的不良后果，尤其是对幼儿而言。在本指南中，我们提供了关于90天以上至14岁婴幼儿社区获得性UTI诊断和管理的最新信息。我们参考了美国儿科学会实践指南、加拿大儿科学会指南及其他国际指南给出的当前建议，以及药敏模式和资源的地区差异。本指南涵盖了在我国最常见尿路病原体的局部抗菌药物耐药模式指导下，儿童社区获得性UTI管理的诊断、治疗选择和预防措施。新生儿、三个月以下婴儿、免疫功能低下患者、复发性UTI儿童或肾脏异常患者应进行个体化管理，因为这些患者可能需要更广泛的检查、更积极的治疗和随访，因此本指南未涉及。制定针对儿童社区获得性UTI诊断和管理的特定指南可降低发病率和死亡率。我们展示了沙特儿科传染病学会（SPIDS）关于儿童社区获得性UTI诊断和管理的临床声明。
